Influence of plasma collection tubes on N-glycome in human blood samples

• Published in: Practical laboratory medicine 2024-03, Vol.39, p.e00383-e00383, Article e00383
• Main Authors: Zhang, Zejian, Cui, Xiangyi, Zhou, Nan, Zhu, Lisi, Zhi, Yuxiang, Zhang, Shuyang
• Format: Article
• Language: English
• Subjects: Citrate; Collection tubes; EDTA; Heparin; N-glycome; Plasma
• ISSN: 2352-5517; 2352-5517
• DOI: 10.1016/j.plabm.2024.e00383

Quantitative analysis of plasma N-glycome is a promising method for identifying disease biomarkers. This study aimed to investigate the impact of using blood collection tubes with different anticoagulants on plasma N-glycome. We used a robust mass spectrometry method to profile plasma N-glycomes in two cohorts of healthy volunteers (cohort 1, n = 16; cohort 2, n = 53). The influence of three commonly used blood collection tubes on fully characterized N-glycomic profiles were explored. Principal component analysis revealed distinct clustering of blood samples based on the collection tubes. Pairwise comparisons demonstrated significant differences between EDTA and heparin plasma in 55 out of 82 quantified N-glycan traits, and between EDTA and citrate plasma in 62 out of 82 traits. These differences encompassed various N-glycan features, including glycan type, sialylation, galactosylation, fucosylation, and bisection. Trends in N-glycan variations in citrate and heparin plasma were largely consistent compared to EDTA plasma. In correlation analysis (EDTA vs. heparin; EDTA vs. citrate), Pearson's correlation coefficients were consistently higher than 0.7 for the majority of N-glycan traits. Sample matrix variations impact plasma N-glycome measurements. Caution is crucial when comparing samples from different plasma collection tubes in glycomics projects. [Display omitted] •Analyzing 82 N-glycan traits in healthy subjects' EDTA, heparin, and citrate plasma.•Nearly all N-glycan features existed variations among the three types of plasma.•Compared to EDTA plasma, N-glycans in citrate and heparin largely consistently changed.•Caution in comparing samples from different sources, like plasma tubes, in glycomics.